BIOMARIN PHARMACEUTICAL INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Biomarin Pharmaceutical Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Biomarin Pharmaceutical Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $119M, a 2.52% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $119M +$2.93M +2.52% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $116M +$7.12M +6.52% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $109M +$16.1M +17.3% Dec 31, 2021 10-K 2023-02-27
Q4 2020 $93.1M +$6.88M +7.98% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $86.2M -$21.7M -20.1% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $108M -$3.07M -2.77% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $111M +$38M +52% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $73M +$5.33M +7.87% Dec 31, 2016 10-K 2018-02-26
Q4 2015 $67.7M +$59.9M +767% Dec 31, 2015 10-K 2017-02-27
Q4 2014 $7.81M -$535K -6.41% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $8.35M Dec 31, 2013 10-K 2015-03-02
Q4 2010 $231M Dec 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.